SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Clinical reasoning amongst paramedics using nebulised β₂ agonists to treat acute asthma exacerbations: a qualitative study.

Mortimer, C; Nikoletou, D; Ooms, A; Williams, J (2024) Clinical reasoning amongst paramedics using nebulised β₂ agonists to treat acute asthma exacerbations: a qualitative study. NPJ Prim Care Respir Med, 34 (1). p. 24. ISSN 2055-1010 https://doi.org/10.1038/s41533-024-00383-w
SGUL Authors: Nikoletou, Dimitra

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (669kB) | Preview
[img]
Preview
PDF (Supplementary Information) Supplemental Material
Download (255kB) | Preview
[img]
Preview
PDF (Reporting Summary) Supplemental Material
Available under License Creative Commons Attribution.

Download (860kB) | Preview

Abstract

The heterogeneous nature of asthma results in a wide range of presentations during exacerbation. Despite UK pre-hospital management guidelines focusing on β₂ agonists, variables such as cause, severity, underlying health, comorbidities, and drug side effects can often make emergency treatment optimisation difficult. This article examines paramedics' methods of observing, perceiving, interpreting, and treating asthma with β₂ agonists, often acting on limited information in rapidly evolving situations. We recruited paramedics from a single UK National Health Service ambulance Trust for qualitative semi-structured interviews. Responses underwent framework analysis to identify data similarities and differences. Fifteen qualitative interviews with paramedics revealed three main themes affecting patient management: clinician experience of presentation, adaptation of patient management approaches, and severity of side effects. Paramedics felt their ability to manage various asthma presentations was enhanced through guideline adaptation based on their own clinical experience and understanding of β₂ agonist side effects, allowing tailored responses based on a set of reinforcing factors. Inductive analysis revealed additional complexities within these themes, such as anxiety and diabetes, which may influence β₂ agonist administration and result in multiple care pathways being initiated during exacerbation. Paramedic care mirrors asthma's complexity, accounting for a range of characteristics. A dynamic, critically thought approach enables patient management to be based on the presenting conditions rather than strict adherence to a single algorithm. Comprehending the complexities and variables in treatment can be crucial to how paramedics rationalise their treatment and optimise the care provided.

Item Type: Article
Additional Information: Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. © The Author(s) 2024
Keywords: Humans, Asthma, Qualitative Research, Adrenergic beta-2 Receptor Agonists, Allied Health Personnel, Nebulizers and Vaporizers, Male, Female, Emergency Medical Services, Interviews as Topic, Adult, United Kingdom, Emergency Medical Technicians, Paramedics
Journal or Publication Title: NPJ Prim Care Respir Med
ISSN: 2055-1010
Language: eng
Dates:
DateEvent
6 September 2024Published
1 August 2024Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 39242609
Web of Science ID: WOS:001306589500001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/116824
Publisher's version: https://doi.org/10.1038/s41533-024-00383-w

Actions (login required)

Edit Item Edit Item